CareTrust REIT, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CareTrust REIT, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $476.39M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $296.29M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $217.77M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $196.13M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $192.35M | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | $44.14M | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $45.69M | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | $44.17M | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | $44.34M | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $44.23M | Feb 10, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $0 | Feb 12, 2026 |
| FY2022 | Dec 31, 2022 | $0 | Feb 9, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Feb 9, 2023 |
| FY2022 | Dec 31, 2020 | $2.08M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $3.39M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $3.38M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $3.23M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $2.97M | Feb 13, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $320.54M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $125.08M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $53.74M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | ($7.51M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $71.98M | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | $21.06M | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | $21.55M | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | $18.94M | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | $19.33M | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | $20.66M | Feb 10, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $394.03M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $244.25M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $154.77M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $144.42M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $156.87M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $145.74M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $126.30M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $99.36M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $88.80M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $64.43M | Feb 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.94M | Feb 20, 2020 |
| FY2019 | Dec 31, 2018 | $1.78M | Feb 20, 2020 |
| FY2019 | Dec 31, 2017 | $403.0K | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $151.0K | Feb 13, 2019 |
| FY2017 | Dec 31, 2015 | $276.0K | Feb 27, 2018 |
| FY2016 | Dec 31, 2014 | $19.28M | Feb 7, 2017 |
| FY2015 | Dec 31, 2013 | $19.93M | Feb 11, 2016 |
| FY2014 | Dec 31, 2012 | $19.76M | Feb 11, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.15B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.44B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.08B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.62B | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $1.64B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $1.50B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $1.52B | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $1.29B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.18B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $925.36M | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $507.63M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $666.12M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $771.41M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $725.09M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $589.42M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $591.27M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $523.52M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $590.37M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $472.93M | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.04B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.91B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.42B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $849.37M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $915.76M | Feb 9, 2023 |
| FY2022 | Dec 31, 2020 | $914.14M | Feb 9, 2023 |
| FY2022 | Dec 31, 2019 | $927.59M | Feb 9, 2023 |
| FY2021 | Dec 31, 2018 | $768.25M | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $594.62M | Feb 10, 2021 |
| FY2019 | Dec 31, 2016 | $452.43M | Feb 20, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $198.04M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $213.82M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $294.45M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $13.18M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $19.90M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $18.92M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $20.33M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $36.79M | Feb 20, 2020 |
| FY2019 | Dec 31, 2017 | $6.91M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $7.50M | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $894.22M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $396.93M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $595.60M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $719.50M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $673.40M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $545.59M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $554.62M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $489.77M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $558.91M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $449.72M | Feb 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 8, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 10, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 10, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 222.75M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 186.99M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 129.99M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 99.01M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | 96.30M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | 95.22M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 95.10M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | 85.87M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 75.48M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 64.82M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $259.35M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $172.17M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $115.49M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $106.14M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $100.78M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $93.16M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $80.62M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $63.00M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $52.59M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $37.27M | Feb 13, 2019 |